Critical Care MCQs

A Companion for Intensive Care Exams

Lobaz, Steven, Hamilton, Mika, Glossop, Alastair J. , Raithatha, Ajay H.

• Éditeur: tfm Publishing Ltd
• Année: 2015
• ISBN:
  9781910079157
• Sujet: Medicine
• Sous-sujet: Emergency Medicine & Critical Care

Critical Care MCQs is the perfect companion for anyone sitting exams in intensive care, as a training resource or just wanting to improve their knowledge in this constantly developing area of medical practice.Written by critical care doctors with experience of UK and European examination formats, this book leads the reader through 450 true/false questions with referenced explanations, covering core syllabus topics and key influential papers to date. A detailed list of further resources and recommendations relevant to critical care revision is also provided to enable readers to further their knowledge and understanding.It is hoped that this book will prove invaluable for preparation and success in upcoming intensive care exams for both candidates and trainers. This book would be useful for not only candidates sitting the UK Final Fellowship of Intensive Care Medicine (FFICM) and European Diploma of Intensive Care (EDIC) exams, but also the Indian Diploma in Critical Care Medicine (IDCCM), the Diploma of the Irish Board of Intensive Care Medicine (DIBICM), the Australia and New Zealand Fellowship of the College of Intensive Care Medicine (CICM), American Board and any other country-related intensive care exams.

“Fortune favours the prepared mind.” Louis Pasteur

1 MCQ Paper 1: Questions

•	Question 1: In relation to the drug sugammadex:
a	It is recommended for immediate reversal of vecuronium.
b	It can effectively reverse cisatracurium.
c	16mg/kg is recommended intravenously for the immediate reversal of rocuronium.
d	It is an α-cyclodextrin that encapsulates aminosteroid neuromuscular blocking agents.
e	Sugammadex may be effective in treating rocuronium-induced anaphylaxis.

•	Question 2: For patients with coronary artery stents undergoing non-cardiac surgery:
a	Non-urgent surgery should be delayed in the immediate post-stent period.
b	Drug-eluting stents (DES) have reduced restenosis rates at 1 year, when compared to bare metal stents (BMS).
c	Bare metal stents (BMS) require 4-6 months of clopidogrel therapy.
d	Dual antiplatelet therapy is associated with an increased peri-operative mortality.
e	Biocompatible stents (e.g. Genous™ R-stent) require peri-operative bridging therapy.

•	Question 3: Regarding The Royal College of Anaesthetists’ 4th National Audit Project (NAP4):
a	Airway complications in intensive care resulted in death or disability in less than 20% of cases.
b	End-tidal CO2 monitoring (capnography) is not always necessary for intubation.
c	A difficult airway trolley is recommended for all intensive care units.
d	Regular audit of airway complications should occur.
e	Transfer of an intubated patient is deemed low risk for airway complications.

•	Question 4: In relation to a potential ‘can’t intubate, can’t ventilate (CICV) scenario’ in anaesthesia practice:
a	It is estimated to occur in 0.01 to 2.0 per 100,000 cases.
b	Jet ventilation is required for cricothyroidotomy with a cannula of >4mm diameter.
c	Over 90% of CICV situations are preventable.
d	Fixation error may lead to loss of situational awareness and poor decision making.
e	Cricothyroidotomy skills are retained for only a ...